Original Article
Model for Assessing the Efficiency of Biologic Drugs in the Treatment of Moderate to Severe Psoriasis for 1 Year in Clinical Practice in Spain
Modelo de eficiencia de los fármacos biológicos en el tratamiento de la psoriasis moderada-grave durante un año en las condiciones de uso en España
Read
6801
Timeswas read the article
2284
Total PDF
4517
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 61 | 30 | 91 |
| 2025 5 | 139 | 29 | 168 |
| 2025 4 | 138 | 22 | 160 |
| 2025 3 | 107 | 25 | 132 |
| 2025 2 | 149 | 35 | 184 |
| 2025 1 | 77 | 33 | 110 |
| 2024 12 | 71 | 23 | 94 |
| 2024 11 | 84 | 54 | 138 |
| 2024 10 | 64 | 44 | 108 |
| 2024 9 | 81 | 28 | 109 |
| 2024 8 | 91 | 56 | 147 |
| 2024 7 | 86 | 32 | 118 |
| 2024 6 | 58 | 27 | 85 |
| 2024 5 | 66 | 39 | 105 |
| 2024 4 | 66 | 23 | 89 |
| 2024 3 | 58 | 35 | 93 |
| 2024 2 | 52 | 27 | 79 |
| 2024 1 | 29 | 24 | 53 |
| 2023 12 | 79 | 19 | 98 |
| 2023 11 | 80 | 27 | 107 |
| 2023 10 | 58 | 22 | 80 |
| 2023 9 | 59 | 24 | 83 |
| 2023 8 | 38 | 14 | 52 |
| 2023 7 | 50 | 37 | 87 |
| 2023 6 | 47 | 28 | 75 |
| 2023 5 | 54 | 28 | 82 |
| 2023 4 | 48 | 19 | 67 |
| 2023 3 | 72 | 22 | 94 |
| 2023 2 | 52 | 21 | 73 |
| 2023 1 | 39 | 23 | 62 |
| 2022 12 | 54 | 49 | 103 |
| 2022 11 | 45 | 32 | 77 |
| 2022 10 | 25 | 22 | 47 |
| 2022 9 | 26 | 48 | 74 |
| 2022 8 | 24 | 39 | 63 |
| 2022 7 | 24 | 36 | 60 |
| 2022 6 | 26 | 29 | 55 |
| 2022 5 | 33 | 58 | 91 |
| 2022 4 | 49 | 40 | 89 |
| 2022 3 | 49 | 56 | 105 |
| 2022 2 | 37 | 40 | 77 |
| 2022 1 | 55 | 43 | 98 |
| 2021 12 | 34 | 45 | 79 |
| 2021 11 | 52 | 49 | 101 |
| 2021 10 | 67 | 56 | 123 |
| 2021 9 | 68 | 41 | 109 |
| 2021 8 | 70 | 34 | 104 |
| 2021 7 | 36 | 25 | 61 |
| 2021 6 | 56 | 26 | 82 |
| 2021 5 | 39 | 39 | 78 |
| 2021 4 | 80 | 61 | 141 |
| 2021 3 | 74 | 25 | 99 |
| 2021 2 | 66 | 21 | 87 |
| 2021 1 | 47 | 24 | 71 |
| 2020 12 | 44 | 14 | 58 |
| 2020 11 | 35 | 23 | 58 |
| 2020 10 | 41 | 19 | 60 |
| 2020 9 | 39 | 19 | 58 |
| 2020 8 | 48 | 25 | 73 |
| 2020 7 | 37 | 21 | 58 |
| 2020 6 | 37 | 41 | 78 |
| 2020 5 | 42 | 25 | 67 |
| 2020 4 | 41 | 21 | 62 |
| 2020 3 | 51 | 30 | 81 |
| 2020 2 | 5 | 3 | 8 |
| 2020 1 | 4 | 2 | 6 |
| 2019 12 | 4 | 2 | 6 |
| 2019 11 | 4 | 0 | 4 |
| 2019 9 | 2 | 3 | 5 |
| 2019 8 | 4 | 2 | 6 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 14 | 2 | 16 |
| 2019 5 | 6 | 0 | 6 |
| 2019 4 | 3 | 1 | 4 |
| 2019 3 | 2 | 6 | 8 |
| 2019 2 | 3 | 0 | 3 |
| 2019 1 | 6 | 0 | 6 |
| 2018 12 | 2 | 0 | 2 |
| 2018 11 | 4 | 0 | 4 |
| 2018 10 | 4 | 0 | 4 |
| 2018 9 | 6 | 0 | 6 |
| 2018 3 | 2 | 1 | 3 |
| 2018 2 | 43 | 4 | 47 |
| 2018 1 | 37 | 6 | 43 |
| 2017 12 | 54 | 5 | 59 |
| 2017 11 | 72 | 7 | 79 |
| 2017 10 | 38 | 8 | 46 |
| 2017 9 | 32 | 8 | 40 |
| 2017 8 | 33 | 5 | 38 |
| 2017 7 | 43 | 9 | 52 |
| 2017 6 | 57 | 8 | 65 |
| 2017 5 | 38 | 8 | 46 |
| 2017 4 | 28 | 10 | 38 |
| 2017 3 | 17 | 6 | 23 |
| 2017 2 | 89 | 11 | 100 |
| 2017 1 | 28 | 8 | 36 |
| 2016 12 | 45 | 21 | 66 |
| 2016 11 | 44 | 26 | 70 |
| 2016 10 | 35 | 33 | 68 |
| 2016 9 | 0 | 1 | 1 |
| 2016 8 | 0 | 7 | 7 |
| 2016 7 | 1 | 4 | 5 |
| 2016 5 | 0 | 6 | 6 |
| 2016 2 | 0 | 15 | 15 |
Show all
